MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.
Authors:
- 15 January 2014
- journal article
- Vol. 7 (1) , 32-40
Abstract
MicroRNAs (miRNAs) are small, non-coding RNAs (18-25 nucleotides) that post-transcriptionally modulate gene expression by negatively regulating the stability or translational efficiency of their target mRNAs. The aim of this study was to investigate the expression pattern of microRNA-107 (miR-107) in human breast cancer, and its potential role in disease pathogenesis. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed to determine the expression level of miR-107 in 30 breast cancer specimens and adjacent normal breast tissues. MTT and colony formation assays, transwell and wound healing test, cell cycle assays were conducted to explore the potential function of miR-107 in human MDA-MB-231 breast cancer cells. Luciferase reporter assays were employed to validate regulation of a putative target of miR-107. The effect of modulating miR-107 on endogenous levels of this target were subsequently confirmed via Western blotting. miR-107 expression was relatively decreased in breast cancer specimens compared with adjacent normal tissues (P<0.01). Overexpression of miR-107 suppressed MDA-MB-231 cell proliferation and migration, meanwhile the cells were arrested at G0/G1 phase. Luciferase assays using a reporter carrying a putative miR-107 target site in the 3', untranslated region (3'-UTR) of CDK8 revealed that miR-107 directly targets CDK8. Overexpression of miR-107 led to downregulation of CDK8 at the mRNA and protein level, as assessed by Western blotting. miR-107 may play an important role in breast cancer progression, which might negatively regulate the expression of CDK8 and inhibit the proliferation and migration of MDA-MB-231 cell line.Keywords
This publication has 20 references indexed in Scilit:
- CDK8 Maintains Tumor Dedifferentiation and Embryonic Stem Cell PluripotencyCancer Research, 2012
- The Role of miR-103 and miR-107 in Regulation of CDK5R1 Expression and in Cellular MigrationPLOS ONE, 2011
- Src: a potential target for the treatment of triple-negative breast cancerAnnals of Oncology, 2011
- miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cellsMedical Oncology, 2011
- E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8Nature, 2008
- Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal CancerCancer Research, 2008
- Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAsCarcinogenesis, 2008
- Different vascular endothelial growth factor (VEGF), VEGF‐receptor 1 and ‐2 mRNA expression profiles between clear cell and papillary renal cell carcinomaBJU International, 2006
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Growth and molecular interactions of the anti-EGFR antibody Cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: New prospects in the treatment of triple-negative/basal-like breast cancerInternational Journal of Oncology, 1992